simvastatin has been researched along with Skin Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altavilla, D; Bagnato, G; Bitto, A; Cinquegrani, M; Irrera, N; Matucci Cerinic, M; Pizzino, G; Roberts, WN; Saitta, A; Sangari, D; Squadrito, F | 1 |
| Kang, TW; Kim, SC; Lee, EH | 1 |
| Manchanda, Y; Sharma, VK | 1 |
3 other study(ies) available for simvastatin and Skin Diseases
| Article | Year |
|---|---|
Simvastatin attenuates the development of pulmonary and cutaneous fibrosis in a murine model of systemic sclerosis.
Topics: Animals; Biopsy, Needle; Blotting, Western; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrosis; Immunohistochemistry; Mice; Mice, Inbred BALB C; Pulmonary Fibrosis; Random Allocation; Reactive Oxygen Species; Scleroderma, Systemic; Sensitivity and Specificity; Simvastatin; Skin Diseases; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A | 2013 |
Successful treatment of xanthoma disseminatum with simvastatin.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Female; Histiocytosis, Non-Langerhans-Cell; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Middle Aged; Simvastatin; Skin Diseases | 2011 |
Intertriginous xanthomas: a marker of homozygous type IIa hyperlipoproteinemia.
Topics: Buttocks; Child; Cholesterol; Cholesterol, LDL; Diagnosis, Differential; Diet, Fat-Restricted; Female; Hand; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Simvastatin; Skin Diseases; Xanthomatosis | 2004 |